Brigitte Mohr, Uta Oelschlaegel, Christian Thiede, Michelle Meredyth Stewart, Gerhard Ehninger, Uwe Platzbecker. The response to lenalidomide of myelodysplastic syndrome patients with deletion del(5q) can be sequentially monitored in CD34+ progenitor cells. Haematologica 2009;94(3):430-431; https://doi.org/10.3324/haematol.13865.